Executive Summary
Across 110 SEC filings from diverse US-listed firms (despite DJIA 30 focus, spanning banks, biotechs, SPACs, energy, and fintech), sentiment is predominantly mixed/neutral (70+ filings), with 25% positive on growth catalysts like revenue surges (avg +20-30% YoY in standouts like Grab, Via, Republic Bancorp) and clinical progress, but offset by cash burns, impairments, and exec churn. Period-over-period trends reveal banking sector resilience (e.g., NIM expansions in Republic +20bps, Northrim +NII 20%) amid rising NPLs (e.g., Home Bancorp 1.25% vs 0.50%), while biotechs show widened losses (PMV +32% YoY) but pipeline advances; energy firms mixed with Mammoth liquidity up to $158M post-divestitures. Capital allocation leans conservative (shelf registrations, buybacks like Dave $70M repurchase, Harley 10b5-1 plan), with SPACs/M&A active (ReserveOne, Vine Hill). Forward-looking catalysts cluster in Q1-Q2 2026 (PMV NDA, Nuvve BESS ops, Aptiv spin-off), signaling near-term volatility but alpha in undervalued growth names. Portfolio implication: Rotate to banks with NIM tailwinds and biotechs with derisked trials, hedge delisting/Nasdaq risks in small caps.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from March 05, 2026.
Investment Signals(12)
- Republic Bancorp↓(BULLISH)▲
Net income +30% YoY to $131M, ROE +17% to 12.31%, NIM +20bps to 5.05%, deposit costs -41bps
- Northrim Bancorp↓(BULLISH)▲
Net income +75% YoY to $64.6M, NII +20% to $135.6M, ROE +49% to 21.7%, dividend +3% to $0.64
- Grab Holdings↓(BULLISH)▲
Revenue +20% YoY to $3.37B, operating profit swing to +$65M from -$168M loss, Financial Services +37%
- Dave Inc.↓(BULLISH)▲
$175M convertible notes priced (upsized), $70.5M share repurchase, conversion premium 32.5% over $210 close
- Clover Health↓(BULLISH)▲
Guides positive FY2026 GAAP net income, 4-Star ratings entry, strong AEP retention, Clover Assistant leverage
- Nuvve Holding↓(BULLISH)▲
1GW pipeline with OMNIA, 50MW Sweden BESS ops Q2 2026, $260-325k/MW-year rev potential
- Ategrity Specialty↓(BULLISH)▲
GWP +33% to $582M, net income +41% to $76M, combined ratio improves 560bps to 88.2%
- Bridger Aerospace↓(BULLISH)▲
Revenue +25% YoY to $122.8M, net income swing to +$4.1M from -$15.6M loss, Adj EBITDA +21%
- Western Alliance↓(BEARISH)▲
$126.4M loan impairment on breached facility, Q1 2026 charge, uncertain recovery
- PMV Pharmaceuticals↓(BEARISH)▲
FY2025 net loss +32% YoY to $77.7M, cash burn +43% to $73.6M, runway only to Q2 2027
- Mammoth Energy↓(BEARISH)▲
FY2025 revenue -3% YoY to $44.3M, Q4 net loss widens to $12.3M, though liquidity $158M
- Home Bancorp↓(BEARISH)▲
NPLs surge to 1.25% from 0.50% YoY, NPAs 1.03% vs 0.45%, despite NI +26%
Risk Flags(9)
- Western Alliance/Impairment↓[HIGH RISK]▼
$126.4M non-cash charge Q1 2026 on loan breach ($42M missed payment), legal remedies uncertain
- Midland States/Exec Turnover↓[MEDIUM RISK]▼
CFO Eric Lemke terminated Mar5 2026 no reason, 37yo interim CFO appointed, governance concerns
- Spirit Aviation/Bankruptcy↓[HIGH RISK]▼
Waives registration rights amid Ch11 filed Aug2025, stock highly speculative, total loss risk
- Presurance/Nasdaq↓[HIGH RISK]▼
Bid price < $1 for 30 days, 180-day cure to Aug31 2026 or delist, reverse split authority to Jun2026
- Iveda Solutions/Nasdaq↓[HIGH RISK]▼
Bid < $1 30 days, 180-day compliance to Sep2 2026, delisting risk despite options
- Vicarious Surgical/Delist↓[HIGH RISK]▼
NYSE delisted Mar3 2026 to OTC 'RBOT', exec salary cuts 25-50% signal distress
- Equity Bancshares/Losses↓[MEDIUM RISK]▼
NI -64% YoY to $22.7M on $53M securities loss, merger costs $8.1M
- NI Holdings/Underwriting↓[MEDIUM RISK]▼
Combined ratio +920bps to 109.9%, FY net loss -$10.4M vs -$6.1M, cat losses exceed retention
- Bunker Hill Mining/Liabilities↓[HIGH RISK]▼
Net loss triples to $93M, silver loan FV loss $49M, deficiency -$56M, pre-production cash burn
Opportunities(9)
- PMV Pharma/NDA Submission↓(OPPORTUNITY)◆
Phase2 34% ORR (50% ovarian), median response 7.6mo, FDA Orphan status, NDA Q1 2027
- ReserveOne/SPAC Combo↓(OPPORTUNITY)◆
Diversified crypto treasury (80% BTC), M3-Brigade merger Jul2025, public via SPAC mid-2026
- Aptiv/Versigent Spin↓(OPPORTUNITY)◆
$1.35B tender + $401M redemption conditional on spin-off + $1.7B dividend, complete Apr1 2026
- Nuvee/OMNIA Partnership↓(OPPORTUNITY)◆
1GW pipeline, 50MW Sweden BESS Q2 2026 ops, exclusive rights, Europe expansion
- Clover Health/2026 Guidance↓(OPPORTUNITY)◆
Positive GAAP NI FY2026, cohort maturation, 4-Star ratings, underwriting model resilient
- Honeywell Aerospace Spin(OPPORTUNITY)◆
$16B notes + $4B credit for Q3 2026 spin, cash distribution, refi prior debt
- Valmont/Auditor Change↓(OPPORTUNITY)◆
Dismiss Deloitte, appoint KPMG FY2026 end, no disagreements, potential clean audit/cleanup
- AMC/Odeon Refi↓(OPPORTUNITY)◆
$425M facility at 10.5% vs 12.75% notes, extends to 2031, balance sheet strengthen by Apr6 2026
- Unity Bancorp/Record Year↓(OPPORTUNITY)◆
$3B assets, ROE 18%, NIM 4.52%, Piper Sandler recognition, AGM Apr23
Sector Themes(6)
- Banking Mixed Resilience◆
12/20 banks show NI growth avg +25-75% YoY (Northrim, Republic, Civista) but NPLs up (Home +150bps, Equity provisions +260%), NIM mixed (+20bps avg outperformers vs compressions); favor strong capital (CET1 13-15%) [IMPLICATION: Selective longs on NIM expanders]
- Biotech Cash Burn vs Progress◆
5 firms (PMV, Tvardi) report losses +20-32% YoY, cash down 38%, runway 1-2yrs, but clinical wins (ORR 34-50%, Orphan Drug); aggregate R&D +19% [IMPLICATION: Catalyst-driven trades pre-NDA Q1'27]
- Energy Services Divest/Shift◆
Mammoth, BKV, Bridger revenue mixed (-3% to +25% YoY), liquidity boosts ($158M, PV-10 +315% BKV), aviation/rentals +175%; impairments offset gains [IMPLICATION: Pivot to high-growth rentals]
- SPACs/M&A Active◆
8 SPACs (ReserveOne, Vine Hill, Drugs Made) with combos (fusion, crypto, nuclear), $50-230M funding, but redemptions dilute 0-14%; irregularities in 2 [IMPLICATION: Monitor redemptions mid-2026 listings]
- Nasdaq Delist Cluster◆
4 small caps (Presurance, Iveda, Vicarious, Virtuix) bid <$1, 180-day cures to Aug-Sep 2026, reverse splits possible [IMPLICATION: Short/avoid until compliance]
- Exec Incentives Up◆
James River CEO target STI/LTI to 150/200% salary, Reservoir NEOs 100-200% bonuses + equity vesting [IMPLICATION: Aligns mgmt with turnaround]
Watch List(8)
Phase2 data supports Q1 2027 submission, monitor ORR 34% sustainability, cash runway Q2 2027
Amended Form10 filed Mar6, complete by Apr1 2026 + $1.7B dividend, tender closes post-spin
10b5-1 plan by Mar13 2026, Q1 earnings call for strategy update Feb10 precedent
50MW Sweden ops Q2 2026, 1GW pipeline 24mo, rev $260-325k/MW-yr potential
FY2026 positive NI guide, monitor AEP retention, Clover Assistant adoption post-Mar6
$126M Q1 charge recovery via legal, counterparty breach updates
Bid compliance by Aug/Sep 2026, reverse splits Jun/Sep deadlines
$156M Mar3, aviation rentals deploy $65M+, Q4 rev trends post-divest $150M
Filing Analyses(110)
06-03-2026
PMV Pharmaceuticals reported FY2025 net loss of $77.7M, a 32% increase from $58.7M in FY2024, driven by R&D expenses rising 19% to $69.9M amid rezatapopt advancement, while G&A expenses fell 39% to $16.3M; cash and equivalents dropped to $112.9M from $183.3M, with net cash used in operations up to $73.6M from $51.3M, providing runway into Q2 2027. Clinical highlights include on-track PYNNACLE Phase 2 enrollment, FDA Orphan Drug Designation for rezatapopt in TP53 Y220C ovarian cancer, NEJM publication of Phase 1 data, and planned NDA submission in Q1 2027, supported by Phase 2 data showing 34% ORR across cohorts and up to 50% in ovarian cancer. However, cash burn acceleration highlights financial pressures despite promising trial progress.
- ·Median duration of response 7.6 months across all cohorts; 8.0 months in ovarian cancer cohort.
- ·Most frequent TRAEs (>15%): nausea, fatigue, blood creatinine increased, ALT increased (mostly Grade 1-2).
- ·FDA Orphan Drug Designation granted March 2, 2026 for rezatapopt in TP53 Y220C positive ovarian, fallopian tube, and primary peritoneal cancer.
- ·Phase 1 PYNNACLE results published in New England Journal of Medicine.
- ·Updated ovarian cancer ORR data presented at 2026 European Society of Gynecologic Oncology Congress.
06-03-2026
Covenant Logistics Group, Inc. (CVLG) filed a Form S-3 shelf registration statement on March 6, 2026, enabling potential future offerings of common stock, preferred stock, debt securities, rights, and warrants through various distribution methods, with proceeds usage to be specified in supplements. As of February 25, 2026, 20,383,043 Class A shares and 4,700,000 Class B shares were outstanding, with Class B shares (100% owned by David Parker and Jacqueline Parker) providing double voting rights and control over corporate actions. The prospectus incorporates risk factors from the 2025 10-K and warns of potential declines in securities value without highlighting any financial performance metrics.
- ·Class B common stock convertible 1:1 to Class A at any time and automatically converts upon transfer outside Parker family.
- ·No shares of preferred stock issued and outstanding as of February 25, 2026.
- ·Annual Report on Form 10-K referenced for year ended December 31, 2025.
- ·Quarterly Report on Form 10-Q filed August 7, 2025, includes Articles of Incorporation as exhibit.
06-03-2026
On March 5, 2026, Midland States Bancorp, Inc. terminated Eric Lemke from his position as Chief Financial Officer of the Company and its subsidiary Midland States Bank, with no specified reason provided. The Company promptly appointed Claire Stack, age 37 and previously Corporate Controller since November 2025, as Vice President – Chief Accounting Officer and interim CFO, leveraging her 15+ years of accounting and finance experience. A Change of Control Agreement was entered with Ms. Stack, offering severance of 150% of salary plus average prior three-year bonuses upon qualifying termination post-change of control, though the CFO departure raises potential governance concerns.
- ·Claire Stack joined as Corporate Controller in November 2025; holds BS in Accounting and Technology Management from Indiana University’s Kelley School of Business; Certified Public Accountant (CPA).
- ·Change of Control Agreement initial term through December 31, 2026; auto-renews annually unless 90 days' nonrenewal notice; post-termination non-compete/non-solicit for 12 months; COBRA coverage up to 12 months on qualifying termination.
- ·Agreement form filed as Exhibit 10.4 to 2025 Form 10-K.
06-03-2026
AGNC Investment Corp. filed a DEFA14A Definitive Additional Materials proxy statement on March 06, 2026, related to their 2026 proxy notice card. The filing consists primarily of boilerplate SEC Schedule 14A disclosures with no substantive financial, operational, or voting updates provided. No quantitative metrics, period comparisons, or material changes are disclosed.
06-03-2026
ReserveOne Holdings, Inc. (Pubco), a wholly-owned subsidiary of ReserveOne, Inc., disclosed communications via X, LinkedIn, and an interview at the Hong Kong DAT Summit regarding its proposed business combination with M3-Brigade Acquisition V Corp., originally agreed on July 7, 2025. CEO Jaime Leverton positioned ReserveOne as the only diversified digital asset treasury company set to go public, with ~80% allocation to Bitcoin and the balance to yield-generating altcoins like Ethereum and Solana. While highlighting investor exposure to the broader crypto ecosystem, extensive forward-looking risks were noted, including deal completion uncertainties, high crypto volatility, regulatory hurdles, and potential high redemptions.
- ·Business Combination Agreement entered July 7, 2025
- ·Communications posted March 5, 2026
- ·SEC Commission File No. 333-291982 for M3-Brigade
- ·Registration Statement on Form S-4 filed, including proxy statement/prospectus
06-03-2026
Canadian Imperial Bank of Commerce (CIBC) filed a Form F-3 registration statement with the SEC on March 5, 2026, to register up to $20 billion in senior debt securities for potential sale on a delayed or continuous basis pursuant to Rule 415, with specific terms to be detailed in future prospectus supplements. The filing highlights risks including geopolitical tensions, regulatory changes, and cyber threats, but provides no current financial performance metrics or period-over-period comparisons. Securities are not insured by CDIC or FDIC and may be subject to bail-in conversion under Canadian law.
- ·Registrant address: 81 Bay Street, CIBC Square, Toronto, Ontario, Canada M5J 0E7
- ·U.S. agent for service: 300 Madison Avenue, 6th Floor, New York, New York 10017
- ·Securities may be bail-inable under subsection 39.2(2.3) of the CDIC Act
06-03-2026
On March 5, 2026, Liberty Live Holdings, Inc. announced that Renee L. Wilm will transition from her role as Chief Legal Officer and Chief Administrative Officer to Senior Advisor, effective later this year. In her new position, Ms. Wilm will continue providing strategic guidance and counsel to the leadership team while supporting key initiatives. The announcement was made by Liberty Media Corporation.
- ·Event reported date: March 5, 2026
- ·Filing date: March 6, 2026
- ·Securities registered: Series A Liberty Live Group Common Stock (LLYVA) and Series C (LLYVK) on Nasdaq Stock Market LLC
- ·Registrant is an emerging growth company
06-03-2026
On March 5, 2026, Liberty Broadband Corporation announced that Renee L. Wilm will transition from her role as Chief Legal Officer and Chief Administrative Officer to Senior Advisor, effective later this year. In her new role, Ms. Wilm will continue providing strategic guidance and counsel to the leadership team while supporting key initiatives. No other changes or financial impacts were disclosed.
- ·Announcement made by Liberty Media Corporation.
- ·Transition effective later in 2026.
06-03-2026
Dave Inc. priced a $175 million (upsized from $150 million) offering of 0% Convertible Senior Notes due 2031, expecting $168 million in net proceeds (or $192.1 million if the $25 million option is exercised fully), to be used for $15.1 million in capped call transactions, $70.5 million to repurchase 334,000 shares, and general corporate purposes including additional repurchases. The notes feature an initial conversion price of $279.13 per share (32.5% premium over $210.67 closing price on March 4, 2026) and a capped call cap price of $421.34 (100% premium). No performance declines noted, but capped calls aim to mitigate dilution risks from potential conversions.
- ·Offering expected to close on March 9, 2026, subject to customary conditions.
- ·Notes mature on April 1, 2031; redeemable after April 6, 2029 under specific conditions.
- ·Initial conversion rate: 3.5825 shares per $1,000 principal amount.
06-03-2026
On March 5, 2026, Spirit Aviation Holdings, Inc. entered into a Consent and Waiver with certain holders of its common stock and warrants, who represent a majority of Registrable Securities, waiving rights under Sections 2.1, 2.2, and 2.3 of the March 12, 2025 Registration Rights Agreement to permit the company to terminate the Form S-1 registration statement (File No. 333-288706). This action occurs during the company's ongoing Chapter 11 bankruptcy cases filed on August 29, 2025, with explicit warnings that trading in common stock is highly speculative and could result in significant or complete loss for holders.
06-03-2026
FTAI Aviation Ltd. announced the immediate appointment of Nicholas McAleese as Chief Financial Officer and Michael Hazan as Chief Accounting Officer, succeeding Eun (Angela) Nam, who is departing after 12 years to pursue an opportunity outside the aviation industry and will assist in the transition. The company highlighted the new executives' internal experience and contributions since 2022 and 2017, respectively, while expressing thanks to Ms. Nam. No financial impacts or disruptions were mentioned.
- ·Nicholas McAleese joined FTAI in 2022 from roles at BHG Financial, Breather, and PwC.
- ·Michael Hazan joined in 2017, previously at Fortress Investment Group and PwC.
- ·Eun (Angela) Nam served FTAI for the last twelve years.
06-03-2026
Via Transportation, Inc. reported FY2025 revenue of $434.3M, up 29% YoY from $337.6M in 2024, driven by 31% Platform revenue growth to $434.3M (with Legacy revenue declining to $0 from $6.8M), customer count rising 23% to 821, and Platform ARR increasing 30% to $476M. Gross profit grew 31% to $171.8M with margin expansion to 40% from 39%. However, operating expenses rose 16% to $248.4M, narrowing operating loss to $76.6M from $83.9M but widening net loss to $96.4M from $90.6M due to a $10.9M loss on extinguishment of convertible notes.
- ·Stock-based compensation expense totaled $31.3M in FY2025, up 47% from $21.2M in FY2024.
- ·Interest expense increased to $7.3M in FY2025 from $4.3M in FY2024.
- ·FY2023 revenue was $248.9M, with net loss of $116.7M attributable to common stockholders.
06-03-2026
Nuveen AMT-Free Quality Municipal Income Fund extended the final mandatory redemption date of its Series 4 Variable Rate Demand Preferred Shares, aggregate liquidation preference $489.5M, from September 11, 2026, to September 11, 2056, effective March 5, 2026. The preferred shares feature weekly dividends set by a remarketing agent with a liquidity provision and are senior to common shares in liquidation and dividends. No performance declines or flat metrics were reported in this disclosure.
- ·Fund's fiscal year end is October 31.
- ·Series 4 shares are not registered under the Securities Act of 1933 and cannot be offered or sold without exemption.
06-03-2026
Wheeler Real Estate Investment Trust, Inc. processed redemptions of 6,502 shares of Series D Cumulative Convertible Preferred Stock on March 5, 2026, at approximately $41.72 per share (including accrued dividends), settling via issuance of 143,914 shares of common stock at a volume-weighted average price of $1.88. This triggered a further adjustment to the conversion price of its 7.00% Subordinated Convertible Notes due 2031 to approximately $1.04 per share (24.12 shares per $25 principal), a 45% discount to $1.88. Cumulatively, 1,777,083 Series D shares have been redeemed with approximately 393,000 common shares issued; as of March 6, 2026, 1,433,983 common shares and 1,640,295 Series D shares remain outstanding.
- ·Next Series D redemption deadline: March 25, 2026; next Holder Redemption Date: April 6, 2026
- ·Redemption forms and FAQs available at https://ir.whlr.us/series-d/series-d-redemption
06-03-2026
Western Alliance Bancorporation disclosed a material non-cash impairment charge of $126.4 million on March 2, 2026, due to counterparties breaching a commercial loan facility and forbearance agreement by failing to make a required $42.125 million principal payment and discontinuing future payments. The outstanding loan balance is $126.4 million, with the charge to be recognized in Q1 2026. The Bank has asserted claims and will pursue legal remedies for recovery, though outcomes remain uncertain amid forward-looking risks.
- ·Filing date: March 6, 2026
- ·Date of earliest event: March 2, 2026
- ·Securities: Common Stock (WAL), Depositary Shares WAL PrA on NYSE
06-03-2026
Total revenues grew 19.6% YoY to $1.36B in 2025 from $1.14B in 2024, with the Options segment driving growth to $1.11B (up 30.0% YoY), while Equities revenues declined 18.3% to $153M and International revenues fell 56.6% to $15M. Revenues less cost of revenues surged 56.2% to $431M, and Adjusted EBITDA increased 142.6% to $199M with a 46.2% margin, but GAAP net loss attributable to MIH was $70M versus $102M net income in 2024, driven by a $108M loss on debt extinguishment and other non-operating items. Operating income improved to $92M from a $2.8M loss, though Futures and Corporate/Other segments posted operating losses.
- ·Loss on extinguishment of debt: $108M in 2025
- ·Unrealized loss on derivative assets: $55M in International segment 2025
- ·Basic EPS: $(1.00) in 2025 vs $1.68 in 2024
- ·Adjusted diluted EPS: $1.82 in 2025 (up 193.5% YoY)
- ·Futures operating loss: $57M in 2025 (worsened from $47M loss in 2024)
06-03-2026
Aptiv PLC announced that its subsidiary Aptiv Swiss Holdings Limited commenced a cash tender offer to purchase up to $1.35B aggregate consideration of several senior notes (including 3.250% due 2032, 5.150% due 2034, 5.750% due 2054, 4.400% due 2046, 4.150% due 2052, 3.100% due 2051, and 5.400% due 2032), conditional on the spin-off of its Electrical Distribution Systems business into Versigent and receipt of at least a $1.7B special dividend from Versigent. Separately, Aptiv announced conditional redemption of the entire $401M outstanding 4.650% Senior Notes due 2029 at a make-whole premium, expected on April 7, 2026, subject to the same conditions. No financial performance metrics were reported.
- ·Tender Offer to Purchase dated March 6, 2026
- ·Redemption of 2029 Notes expected April 7, 2026
- ·All transactions subject to Spin-Off consummation and $1.7B minimum special dividend
06-03-2026
PMV Pharmaceuticals reported a widened net loss of $77.7M for the year ended December 31, 2025, up 32% YoY from $58.7M in 2024, driven by a 19% increase in R&D expenses to $69.9M despite a 39% reduction in G&A expenses to $16.3M. Total operating expenses rose slightly by 0.9% to $86.2M, while cash and financial assets declined sharply 38% to $112.9M from $183.3M, with operating cash burn increasing 43% to $73.6M. Stockholders' equity decreased to $104.7M from $176.1M amid ongoing losses.
- ·Net loss per share was $1.48 basic and diluted for 2025, compared to $1.14 in 2024.
- ·Auditor emphasis on estimating R&D accruals and prepaids due to high subjectivity.
- ·Total assets decreased to $116.6M as of Dec 31, 2025 from $191.3M as of Dec 31, 2024.
- ·Accumulated deficit grew to $446.5M as of Dec 31, 2025 from $368.7M as of Dec 31, 2024.
- ·Filing date: March 06, 2026.
06-03-2026
For the nine months ended December 31, 2025, Virtuix Holdings Inc. reported net sales growth of 41% YoY to $3.0M and gross profit of $0.9M versus a $0.4M loss in the prior year, driven by lower cost of goods sold and sharply reduced operating expenses (G&A down 57% YoY); however, the net loss narrowed to $6.9M from $12.0M YoY amid high interest expense and debt extinguishment loss. Q3 2025 net sales declined 24% YoY to $1.0M, resulting in a $2.7M net loss versus $2.0M prior year, while selling expenses surged 199% YoY. Balance sheet reflects total assets up 10% to $6.4M with cash doubling to $1.1M, but current liabilities rose 48% to $8.7M due to increased notes payable, deepening stockholders' deficit to $3.0M from $0.8M.
- ·Preferred stock fully converted/reclassified to common stock by Dec 31 2025 (0 shares outstanding vs 21.7M at Mar 31 2025)
- ·Current notes payable doubled to $5.3M from $2.6M QoQ
- ·Inventory slightly down 5% QoQ to $1.4M
- ·Deferred revenue decreased 59% QoQ to $0.7M
- ·Financing activities: $3.0M from convertible notes, $1.9M preferred stock issuance
- ·Loss on debt extinguishment $123K in nine months 2025
06-03-2026
Eightco Holdings Inc. (ORBS) filed an 8-K on March 6, 2026, under Items 7.01 and 9.01, disclosing a press release providing an operational update, attached as Exhibit 99.1 and furnished pursuant to Regulation FD. The information is explicitly not deemed 'filed' under the Exchange Act or subject to its liabilities. No specific financial or operational metrics were detailed in the filing.
- ·Registrant is an emerging growth company.
- ·Common Stock: $0.001 par value, traded as ORBS on Nasdaq.
- ·Principal executive offices: 101 Larry Holmes Drive Suite 313, Easton, PA 18042.
06-03-2026
Mammoth Energy Services reported Q4 2025 revenue from continuing operations of $9.5M, down 5% YoY from $10.0M and 13% QoQ from $10.9M, with full-year revenue at $44.3M, down 3% YoY from $45.6M; net loss widened to $12.3M in Q4 (vs $9.6M YoY) but improved FY to $63.8M from $183.1M. While rental services revenue surged 175% YoY to $3.3M and infrastructure grew 200% to $1.2M, natural sand proppant declined 67% YoY to $1.7M and accommodation fell 17% FY YoY; Adjusted EBITDA remained negative at ($6.8M) Q4, though FY improved significantly to ($17.4M). Four divestitures generated over $150M in cash, bolstering liquidity to $158.3M at year-end, with $65M+ deployed into high-growth aviation rentals.
- ·SG&A expense FY 2025: $19.6M vs $114.5M in 2024 (83% decline, due to lower expected credit losses on PREPA settlement).
- ·Drilling services FY revenue flat at $3.7M vs $3.6M YoY (+3%).
- ·As of Mar 3, 2026, total liquidity $156.6M (cash $89.6M, marketable securities $28.8M).
- ·Q4 sand avg sales price $18.56/ton vs $22.54 YoY (-18%).
06-03-2026
Clover Health Investments, Corp. (CLOV) published written responses to a selection of frequently asked supplemental shareholder questions related to its fourth quarter 2025 earnings announcement on March 6, 2026. The Q&A is furnished as Exhibit 99.1 to this Form 8-K and available on the company's investor relations website. This disclosure is pursuant to Regulation FD and not deemed 'filed' for purposes of the Exchange Act.
- ·Related to fourth quarter 2025 earnings announcement.
- ·Securities registered: Class A Common Stock, par value $0.0001 per share (CLOV).
- ·Remote-first company with no physical headquarters; communications to secretary@cloverhealth.com.
06-03-2026
Future Vision II Acquisition Corp. (FVNNR), a SPAC, filed its 10-K annual report for the year ended December 31, 2025, highlighting ongoing risks related to completing an initial business combination within 18-24 months from IPO closing, potential conflicts of interest among officers and directors, and PRC-related regulatory hurdles. The filing details acquisition criteria focused on revenue growth, free cash flow generation, and public company benefits but notes no business combination has occurred, with financial statements covering the period from inception (January 30, 2024). Risks include dilution from convertible loans up to $1.5M and founder shares purchased at $0.017 per share.
- ·Financial statements cover year ended December 31, 2025 and period from January 30, 2024 (inception) through December 31, 2024.
- ·Initial business combination deadline: 18 months from IPO closing (extendable to 24 months).
- ·PRC regulatory risks including data security oversight by Cyberspace Administration of China and potential need for approvals.
06-03-2026
Harley-Davidson, Inc. intends to enter a Rule 10b5-1 trading plan on or before March 13, 2026, to repurchase a modest amount of its common stock over the coming months, depending on market conditions, consistent with its measured approach to share repurchases announced on the Q4 2025 earnings call on February 10, 2026. The company plans to provide updated information on its share repurchase strategy during the Q1 2026 earnings call. No specific repurchase volumes, pricing, or timelines were disclosed.
- ·Q4 2025 earnings call held on February 10, 2026
- ·SEC filing dated March 6, 2026 under Item 8.01 Other Events
06-03-2026
Marriott Vacations Worldwide Corporation announced that Executive Vice President and General Counsel James Hunter will transition from his role on March 9, 2026, and retire on April 1, 2026, after nearly 20 years of service, including key roles in expansions, the 2011 spin-off from Marriott International, and the 2018 merger with ILG. CEO Matt Avril expressed thanks for Hunter's contributions in building teams and industry leadership, noting he will remain in an advisory role through retirement to ensure a smooth transition. The announcement highlights the company's 120 vacation ownership resorts and approximately 700,000 owner families.
- ·Hunter began in-house legal career at Marriott International in 1994, supporting global development in Asia-Pacific.
- ·Relocated to Orlando in 2006 to lead Law Department of Marriott Vacation Club International.
- ·Hunter will assume presidency of Florida Citrus Sports in April 2026.
06-03-2026
Clover Health Investments, Corp. (CLOV) published supplemental shareholder Q&A on March 6, 2026, providing clarity on Q4 2025 performance, 2026 outlook, and business model strengths in Medicare Advantage. The company guides to positive full-year GAAP Net Income profitability in 2026, anchored by cohort maturation, deeper Clover Assistant engagement, operating leverage, and exceptional retention from AEP, while entering 2026 at 4-Star ratings. They emphasize a model retaining full underwriting risk, less sensitive to industry rate cycles, with focus on clinical integration over broker commissions.
06-03-2026
Honeywell announced that Honeywell Aerospace Inc. has launched a private offering of up to $16B in senior notes and entered into $3B five-year and $1B 364-day revolving credit facilities to finance the planned spin-off of Aerospace, expected in Q3 2026. Proceeds from New Money Notes will fund a cash distribution to Honeywell and related fees, while Exchange Notes settle prior debt obligations. However, the offering size, timing, and terms are subject to market conditions, with significant risks including potential delays, failure to complete the spin-off, or lack of anticipated benefits.
- ·Notes offered only to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S
- ·Notes guaranteed by Honeywell until Spin-Off completion, after which guarantees are automatically released
- ·Closing of Notes offering not contingent on Spin-Off completion
06-03-2026
Korn Ferry (NYSE: KFY) announced the election of Pete Shimer, former Chief Operating Officer of Deloitte U.S., to its Board of Directors, with appointments to the Audit Committee and Nominating and Corporate Governance Committee. Shimer brings extensive consulting, operational, financial, and strategic investment expertise from his Deloitte career, including roles as Interim CEO, CFO, and Lead Client Service Partner for Fortune 500 clients. CEO Gary D. Burnison and Non-Executive Chair Jerry Leamon highlighted his value in enhancing board capabilities.
- ·Pete Shimer earned a Bachelor of Arts in Accounting from the University of Washington.
- ·Shimer currently serves as Executive Committee Chair of the Cancer Artificial Intelligence Alliance, Board member of Alaska Air Group (Audit and Safety Committees), Synopsys (Audit Committee), Fred Hutchinson Cancer Center (Executive Committee Vice Chair), and University of Washington Foster School of Business.
- ·Filing references Korn Ferry’s Annual Report on Form 10-K for fiscal year ended April 30, 2025.
06-03-2026
Chilean Cobalt Corp. amended its binding earn-in and option agreement with NeoRe SpA on March 2, 2026, clarifying the NeoRe Rare Earth Project properties at 6,300 hectares across 21 mining concessions without altering financial terms. The company issued a press release announcing land expansion by 2,100 hectares through 7 new concessions, initial drilling of 192 meters with intercepts up to 1,060 ppm TREE and surface samples over 800 ppm, and an accelerated program targeting Tranche 1 completion by July 2026. Exploration has identified over 20 additional targets, with ongoing metallurgical testing of more than 100 samples supported by University of Concepción and CORFO.
- ·Amendment filed March 6, 2026, references prior 8-K on January 14, 2026.
- ·Drilling transition to execution phase with two parallel crews planned.
- ·Conceptual engineering initiated for modular processing including crushing and milling circuit.
- ·CORFO award supports analytical and metallurgical work.
06-03-2026
Nuvve Holding Corp. announced a partnership with OMNIA Global to address a 1GW development pipeline over the next 24 months, supported by financing, starting with a 50MW/75MWh battery energy storage system (BESS) in Sweden expected to commence operations in Q2 2026. Nuvve will own and manage the facility, providing market access services, with potential revenues of $260,000–$325,000 per MW-year amid favorable Swedish market conditions. The deal includes exclusive rights to support OMNIA's projects and a right of first refusal for future ownership stakes, expanding Nuvve's European footprint.
- ·Filing date: March 06, 2026
- ·First project operations expected: Q2 2026
- ·Pipeline timeframe: next 24 months
- ·Nuvve headquartered in San Diego, California
06-03-2026
GSK plc reported 2025 turnover of £32.7B, up 4% AER and 7% CER from £31.4B in 2024, driven by strong operating profit growth of 97% AER to £7.9B and profit attributable to shareholders more than doubling to £5.7B. However, performance was mixed across products, with growth in Dovato (+20% AER), Jemperli (+84%), and Shingrix (+6%) offset by declines in Triumeq (-25%), Seretide/Advair (-19%), and Rotarix (-7%). Vaccine sales totaled £9.2B, flat AER but +2% CER, while R&D expenses rose 18% to £7.5B.
- ·Scope 1 & 2 emissions from energy/sales revenue improved to 8.8 tonnes CO2e/£m in 2025 from 10.6 in 2024.
- ·Total energy used decreased to 2,482 GWh in 2025 from 2,577 GWh in 2024.
- ·% renewably sourced electricity reached 99% in 2025, up from 90% in 2024.
- ·Total waste reduced to 39,000 metric tonnes in 2025 from 47.3k in 2024.
06-03-2026
Solitron Devices, Inc. (SODI) has issued a proxy statement for its 2025 Annual Meeting on April 24, 2026, seeking stockholder approval for the re-election of Charles M. Gillman as Class III director for a term until the 2028 Annual Meeting, ratification of Whitley Penn LLP as independent auditors for the fiscal year ending February 28, 2026, and a non-binding advisory vote on named executive officer compensation. The record date is February 27, 2026, with 2,147,703 shares of common stock outstanding entitling holders to vote. The Board consists of five directors divided into three staggered classes, with no financial performance metrics or period comparisons disclosed in the filing.
- ·Annual Meeting time: 10:00 a.m. Eastern Time at 901 Sansburys Way, West Palm Beach, Florida 33411
- ·Proxy materials mailing date: on or about March 10, 2026
- ·Fiscal year reference: ended February 28, 2025 (10-K available)
- ·Voting quorum: majority of issued and outstanding shares present in person or by proxy
- ·Majority voting standard for uncontested director elections with contingent resignation provision
- ·Committee memberships: Audit (Dwight P. Aubrey, John F. Chiste); Compensation (Dwight P. Aubrey, David W. Pointer, Charles M. Gillman); Nominating (John F. Chiste, David W. Pointer, Charles M. Gillman)
06-03-2026
On February 28, 2026, Lynn Stockwell was removed as Chief Executive Officer, Executive Chair, and Board member due to the Sponsor's improper withdrawals totaling $1.1M from working capital post-IPO, including a $566k overpayment that was not returned despite Board demands. Roger Bendelac was appointed as the new CEO effective the same date, with compensation to be determined later. The incident highlights governance issues but ensures leadership continuity.
- ·Sponsor withdrawals occurred between IPO completion on September 26, 2025, and September 30, 2025 ($1.1M), with additional overpayment adjustments through December 31, 2025.
- ·Board directed Sponsor to return full overpayment on February 12, 2026; Stockwell agreed to resign on February 18, 2026.
- ·Roger Bendelac, 69, has over 30 years in investment banking; no family relationships or related party transactions with the Company.
06-03-2026
On February 28, 2026, Lynn Stockwell was removed as Chief Executive Officer, Executive Chair of the Board, and Board member of Drugs Made In America Acquisition Corp. following issues with the sponsor of its affiliate, Drugs Made In America Acquisition II Corp., which improperly withdrew $1.1M from the affiliate's working capital account between September 26 and September 30, 2025, including a $566,269 overpayment and at least $200,000 more for unrelated expenses. Roger Bendelac was appointed as the new CEO effective the same date, with compensation to be determined later. The resignations stem from the sponsor's inability to repay overpayments as directed on February 12, 2026.
- ·Sponsor withdrawals from affiliate occurred between completion of affiliate's IPO on September 26, 2025, and September 30, 2025; additional withdrawals between September 30, 2025, and December 31, 2025.
- ·Affiliate Board directed sponsor to return full overpayment on February 12, 2026; learned on same date sponsor unable to repay.
- ·Stockwell agreed to resign on February 18, 2026, at request of both Company and Affiliate Boards; resignation effective February 28, 2026 upon receipt.
06-03-2026
Independent Bank Corporation (IBCP) filed Definitive Additional Proxy Materials (DEFA14A) on March 06, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as Definitive Additional Materials rather than a preliminary or full proxy statement.
- ·Filing categorized as Definitive Additional Materials under Schedule 14A.
06-03-2026
Vertiv Holdings Co (VRT) filed an 8-K on March 6, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), with a filing size of 251 KB. No specific financial metrics, period-over-period comparisons, or detailed event descriptions are available in the provided filing index. The document appears to report a general update with potential exhibits.
- ·CIK: 0001674101
- ·SIC: 3679 (Electronic Components, NEC)
- ·Fiscal Year End: December 31
- ·State of Incorporation: DE
- ·Business Address: 505 N. Cleveland Ave., Westerville, OH 43082
- ·Accession Number: 0001628280-26-015494
06-03-2026
Independent Bank Corporation's 10-K for FY ended December 31, 2025, reports total loans of $4.276B and deposits of $4.762B, with the bank maintaining well-capitalized status. Revenue mix shifted with interest and fees on loans rising to 75.7% in 2025 from 70.7% in 2024 and 68.1% in 2023; however, other interest income declined to 9.8% from 11.8% and 14.4%, while non-interest income fell to 14.5% from 17.4% and 17.5%. The company operates 56 branches in Michigan, employs 735 full-time and 91 part-time staff, and had 20.6M shares outstanding as of March 5, 2026.
- ·One loan production facility in Ohio (Fairlawn).
- ·Acquisition of Traverse City State Bank completed in April 2018.
- ·Annual Meeting of Shareholders scheduled for April 21, 2026.
06-03-2026
Independent Bank Corporation's DEF 14A proxy statement for the 2026 Annual Meeting on April 21, 2026, seeks shareholder approval to elect four directors (Terance L. Beia, Stephen L. Gulis Jr., William B. Kessel for three-year terms expiring 2029; Michael G. Wooldridge for one-year term expiring 2027), ratify Crowe LLP as auditors for FY 2026, and advisory votes on executive compensation and frequency. As of the February 20, 2026 record date, 20,769,374 common shares were outstanding, with no performance metrics reported but major 5%+ beneficial owners disclosed including BlackRock (9.0%), Vanguard (6.4%), and FMR LLC (5.0%). Board size is fixed at 10 members.
- ·Annual Meeting: April 21, 2026 at 3:00 p.m. ET, virtual at www.virtualshareholdermeeting.com/IBCP2026
- ·Record date: February 20, 2026
- ·Michael G. Wooldridge appointed to Board in December 2025
- ·Notice of Internet Availability mailed on or about March 6, 2026
06-03-2026
Republic Bancorp, Inc. reported robust 2025 financial results, with net income surging 30% YoY to $131.3M, diluted EPS up 29% to $6.72, ROA improving 25% to 1.84%, and ROE rising 17% to 12.31%, fueled by net interest income growth to $334.7M (up 7% YoY) and NIM expansion to 5.05% from 4.85%. Average interest-bearing deposits grew 6% or $203M, with costs declining to 2.26% from 2.67%, reducing interest expense by 10% or $9.6M. However, the Traditional Bank booked a $4.8M specific provision on a $16M C&I participation loan in Q4 2025 amid borrower revenue declines and expense pressures, while TRS Refund Advances and Other RPG loans saw average balances decrease.
- ·Noninterest-bearing deposits average balance declined $42.6M YoY to $1.33B in 2025.
- ·Allowance for credit losses stable at approx. $92M in 2025 vs 2024.
- ·Stockholders’ equity average grew to $1.07B in 2025 from $965M in 2024.
06-03-2026
Peoples Bancorp Inc. (PEBO) filed its DEF 14A proxy statement for the virtual annual shareholder meeting on April 23, 2026, at 10:00 a.m. EDT, with a record date of February 23, 2026. Key proposals include electing eleven directors for one-year terms expiring at the 2027 meeting, an advisory vote to approve named executive officers' compensation as disclosed, and ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing excerpt.
- ·Meeting held solely via live webcast at www.proxydocs.com/pebo; no in-person attendance.
- ·Shareholder proposals for 2027 annual meeting must be received by December 2026 (specific date not provided in excerpt).
06-03-2026
Information Services Group Inc. reported total revenues of $244.7M for the year ended December 31, 2025, down 1% from $247.6M in 2024, with Americas up 1% to $160.9M but offset by declines in Europe (-3% to $65.5M) and Asia Pacific (-13% to $18.3M). Operating expenses fell 6% to $226.9M, driving net income higher to $9.3M from $2.8M and Adjusted EBITDA up 28% to $32.2M from $25.1M. Cash provided by operating activities improved to $29.0M from $19.9M.
- ·Adjusted net income increased to $16.5M from $9.97M YoY.
- ·Adjusted net income per diluted share rose to $0.33 from $0.20.
- ·Net cash used in investing activities was $4.9M in 2025 vs provided by $19.0M in 2024.
- ·Gain on sale of business declined 84% to $0.7M from $4.5M.
- ·Total other expense, net worsened to $(3.3M) from $(0.5M).
06-03-2026
Northrim Bancorp reported net income of $64.6M for 2025, surging 75% YoY from $37.0M in 2024, fueled by net interest income growth of 20% to $135.6M and other operating income jump of 84% to $77.2M, while assets expanded 8% to $3.29B and ROE rose to 21.7% from 14.7%. However, nonperforming loans increased to $11.3M (0.49% of portfolio) from $7.5M (0.35%), provision for credit losses rose 19% to $3.9M, and other operating expenses grew 16% to $122.1M. Dividend per share increased slightly to $0.64 from $0.62.
- ·Five-year compound growth rate for net income: 14%
- ·Tangible book value per share: $12.47 (2025) vs $9.79 (2024)
- ·Allowance for credit losses to portfolio loans stable at 1.03% (2025 and 2024)
- ·Total employees grew 3% over five years to 516 FTE
- ·Common shares outstanding five-year CAGR: -2%
06-03-2026
Great Southern Bancorp, Inc. reported net income of $71M for the year ended December 31, 2025, up 15% YoY from $62M in 2024, driven by a 6% increase in net interest income to $200M and no provision for credit losses on loans. However, total assets declined 6% YoY to $5.6B, net loans receivable fell 7% to $4.4B, and deposits decreased 3% to $4.5B amid higher interest expense pressures. Non-performing assets improved 15% to $8.1M (0.14% of average total assets), while foreclosed assets ticked up slightly to $6.0M.
- ·Tier 1 capital ratio for Great Southern Bancorp, Inc. at 14.1% as of Dec 31, 2025 (up from 12.8% in 2024).
- ·Efficiency ratio improved to 61.91% in 2025 from 64.40% in 2024.
- ·Subordinated debentures balance stable at $25.8M across 2023-2025.
- ·Average subordinated notes balance declined sharply to $34.1M in 2025 from $74.7M in 2024.
06-03-2026
The 2026 Proxy Statement for First Bancorp, Inc. (FNLC) details governance practices, including the Audit Committee's financial expertise led by independent Chair F. Stephen Ward, procedures for related party transactions exceeding $120,000 (none in 2025 except ordinary loans of $28.3M to directors/executives, or 1.21% of total loans), and no adopted written policy but established review processes. Director compensation from the Bank totaled $291,100 in 2025, with 54% reinvested via stock purchase plan and no fees paid to the Company for directorships. Executive officer bios highlight long tenures and recent promotions/appointments in 2025-2026.
- ·Director fees structure: Chair $44,600 annual; others $1,400 monthly retainer, $1,050 per board meeting, $700 per committee meeting.
- ·Code of Business Conduct and Ethics re-approved Sept 25, 2025; available on investor website.
- ·Internal audits outsourced except loan review; Bank regulated by OCC, FDIC, Federal Reserve.
- ·Ms. Kachmar joined Board Feb 2025; several executives promoted Feb 2025.
06-03-2026
NI Holdings reported direct written premiums of $289.8M for FY 2025, down 15.3% YoY, and net earned premiums of $270.7M, down 12.7% YoY, primarily due to strategic reductions in the Non-Standard Auto segment including exits from Illinois, South Dakota, and Arizona. The combined ratio deteriorated to 109.9% for the year (up 9.2 points YoY) and 109.6% for Q4 (up 29.6 points), driven by unfavorable reserve development, catastrophe losses exceeding $20M reinsurance retention in North Dakota, and increased liability claim severity, resulting in a FY net loss of $10.4M versus a prior-year loss of $6.1M. However, net investment income grew 6.9% YoY to $11.7M, supported by higher fixed income balances and favorable rates, while Home and Farm saw growth from new business and rate increases.
- ·Loss and LAE ratio increased 7.3 pts YoY to 74.2% for FY and 21.9 pts to 67.7% for Q4.
- ·Expense ratio up 1.9 pts YoY to 35.7% for FY and 7.7 pts to 41.9% for Q4.
- ·Return on average equity -4.3% for FY 2025 vs 2.8% prior year.
- ·Historic Q2 2025 catastrophe in North Dakota exceeded $20M reinsurance retention, triggering reinstatement premiums.
- ·Company conversion to stock form on March 13, 2017.
06-03-2026
First Bancorp, Inc. reported FY2025 net income of $34.4M, up 27% YoY from $27.0M, with net interest income rising 21% to $77.4M driven by 7% loan growth to $2.39B and a 15 bps expansion in net interest margin to 2.63%. Total assets increased 5% to $3.19B and GAAP efficiency ratio improved to 53.8% from 58.8%. However, savings deposits declined 6% YoY to $258.3M, interest income from interest-bearing deposits fell $0.15M, and net unrealized losses on AFS securities narrowed only slightly to $37.3M.
- ·Non-GAAP efficiency ratio improved to 52.09% from 56.66%.
- ·Pre-tax, pre-provision net income rose to $43.8M from $33.1M.
- ·Average tangible common equity increased to $237.3M from $219.0M.
- ·Securities available for sale decreased slightly to $274.2M from $275.7M.
06-03-2026
NI Holdings, Inc. reported total direct premiums written (DPW) of $289.8M for the year ended December 31, 2025, a 15.4% decline from $342.3M in 2024, driven by sharp drops in Illinois (-70.9%), Arizona (-71.6%), and Nebraska (-4.6%), while North Dakota grew 5.2% to $176.3M and Minnesota surged 65.5%. Battle Creek Mutual Insurance Company converted to a stock company and became a wholly-owned subsidiary on January 2, 2024, and Westminster American Insurance Company was sold on June 30, 2024. South Dakota DPW remained nearly flat at -1.1%.
- ·NI Holdings holds ≥60% ownership in Nodak Mutual Group, Inc.
- ·100% ownership in Direct Auto Insurance Company, Nodak Insurance Company subsidiaries: American West, Battle Creek, Tri-State Ltd (100% in Primero).
- ·North Dakota Secretary of State approved Battle Creek conversion from mutual to stock on January 2, 2024; surplus note paid in full.
- ·Westminster sold to Scott Insurance Holdings on June 30, 2024.
06-03-2026
On March 2, 2026, James River Group Holdings, Inc. amended CEO Frank D’Orazio’s target short-term incentive plan award from 100% to 150% of his base salary and his target long-term incentive plan award from 100% to 200% of his base salary. The company also amended its Code of Conduct to enhance provisions on confidential information obligations and to clarify compliance with the Employee Handbook, with no waivers granted. These changes reflect enhanced executive compensation incentives alongside routine governance updates.
- ·Event reported date: March 2, 2026; Filing date: March 6, 2026
- ·Amended Code of Conduct filed as Exhibit 14.1 and available at https://jrvrgroup.com/our-group/governance/corporate-governance
06-03-2026
National Energy Services Reunited Corp. (NESR) reported total revenue of $1.32B for the year ended December 31, 2025, up 1.7% YoY from $1.30B in 2024, driven by 2.6% growth in the MENA segment to $1.32B. However, Rest of World revenue declined 57% YoY to $8.1M from $18.8M, reflecting underperformance outside core markets. The 10-K extensively details risks including oil price volatility, geopolitical instability in MENA, competitive pressures, and the company's transition from foreign private issuer status effective January 1, 2026.
- ·As of January 1, 2026, NESR is no longer a foreign private issuer and must comply with U.S. domestic issuer requirements under the Exchange Act and Nasdaq rules.
- ·Domestic (BVI) revenue remained at $0 across 2023-2025.
- ·Extensive risk disclosures include oil/gas price volatility, MENA geopolitical tensions (e.g., U.S.-Israel-Iran conflict), currency fluctuations, debt covenants, and ESG/climate pressures.
06-03-2026
AGNC Investment Corp. has issued its proxy statement for the 2026 Annual Meeting of Stockholders on April 16, 2026 (virtual format), seeking approval to elect 10 directors (8 independent), an advisory vote on executive compensation, and ratification of Ernst & Young LLP as independent auditor for the year ending December 31, 2026. From its May 2008 IPO through December 31, 2025, AGNC declared over $15B in common stock dividends ($50.08 per share) and delivered a 559% total stock return, outperforming the S&P 500 Financials Index (264%), FTSE NAREIT Mortgage REITs Index (143%), and S&P 500 Real Estate Index (122%). The Board highlights strong stockholder engagement, including 180 investor meetings and outreach to top 50 stockholders representing 87% of institutional ownership, with no notable declines in performance metrics reported.
- ·Record date for voting eligibility: February 20, 2026
- ·Proxy materials first distributed on or about March 6, 2026
- ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/AGNC2026
- ·In 2025, published fifth annual Corporate Responsibility Report with SASB and TCFD disclosures; offset 2024 Scope 2 GHG emissions and recorded zero Scope 1 emissions
- ·Morris A. Davis rejoined Board in January 2026 after prior service and role as Chief Housing Economist at Council of Economic Advisors
06-03-2026
Unity Bancorp, Inc. (UNTY) filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Shareholders on April 23, 2026, held virtually at 8:00 A.M. local time via meetnow.global/MCJW47X. The proxy solicits votes for the election of five director nominees (George Boyan, Wayne Courtright, David D. Dallas, Robert H. Dallas, Peter E. Maricondo) and ratification of Wolf & Company, P.C. as independent auditors for the year ending December 31, 2026, with the Board recommending FOR all proposals. No financial performance data or period comparisons are included in the materials.
- ·Proxy holders: James A. Hughes and George Boyan
- ·Voting options: Online at www.investorvote.com/UNTY, phone 1-800-652-VOTE (8683), or mail
06-03-2026
Presurance Holdings, Inc. received a Nasdaq notice on March 3, 2026, stating non-compliance with the minimum bid price requirement under Rule 5550(a)(2), as its common stock (PRHI) closed below $1.00 per share for 30 consecutive business days. The company has 180 calendar days until August 31, 2026, to regain compliance by closing at or above $1.00 for 10 consecutive business days, potentially via a reverse stock split approved by shareholders in June 2025. Failure to comply risks delisting, with no assurance of success despite available options.
- ·Nasdaq Marketplace Rule 5550(a)(2) violated; Rule 5810(c)(3)(A) provides initial 180-day cure period.
- ·Board has authority to effect reverse stock split until June 3, 2026, if deemed in shareholders' best interests.
- ·Eligibility for second 180-day period requires meeting other Nasdaq Capital Market initial listing standards except bid price.
06-03-2026
Tvardi Therapeutics, Inc. announced June 9, 2026, as the date for its 2026 Annual Meeting of Stockholders. Stockholder proposals under Rule 14a-8 must be received by March 16, 2026, to be included in the proxy materials, while advance notices for director nominations and other matters per the Bylaws are due by the same date, and Rule 14a-19 notices by April 10, 2026.
- ·Principal executive offices: 3 Sugar Creek Ctr. Blvd. Suite 525, Sugar Land, Texas 77478
- ·Registrant's telephone number: (713) 489-8654
- ·Common Stock: par value $0.001 per share, trading symbol TVRD
06-03-2026
Unity Bancorp, Inc. (UNTY) filed its 2026 definitive proxy statement for the Annual Meeting on April 23, 2026, seeking shareholder approval to elect five director nominees (Wayne Courtright, David D. Dallas, Robert H. Dallas II, Peter E. Maricondo, and George Boyan) and ratify Wolf & Company P.C. as independent auditors for the year ending December 31, 2026. The company highlighted a record 2025 with $3.0B in assets, $2.3B in deposits, diluted EPS of $1.52, ROE of 18.07%, ROA of 2.17%, and net interest margin of 4.52%. Additional achievements include Piper Sandler recognitions and over $340,000 in 2025 donations.
- ·Annual Meeting record date: February 27, 2026
- ·Meeting location: virtual at meetnow.global/MCJW47X, 8:00 AM EDT
- ·Proxy materials available online on or about March 6, 2026; Notice mailed March 12, 2026
- ·Board divided into three classes; electing 4 directors for 3-year terms to 2029 and 1 for 1-year term to 2027
06-03-2026
Harvard Bioscience, Inc. (HBIO) held a Special Meeting of Stockholders on March 6, 2026, with 27,715,066 shares present (61.97% quorum), overwhelmingly approving a reverse stock split proposal (27,004,721 FOR vs. 677,700 AGAINST). The Board selected a 1-for-10 ratio, effective 4:30 p.m. ET on March 13, 2026, reducing outstanding common shares from 44,179,894 to approximately 4,471,989 while authorized shares remain at 80,000,000. The adjournment proposal was also approved (26,970,042 FOR), and split-adjusted trading under HBIO begins March 16, 2026, with a new CUSIP.
- ·Record date: January 21, 2026
- ·Proxy statement filed: January 30, 2026
- ·Adjournment Proposal votes: 26,970,042 FOR, 630,369 AGAINST, 114,655 ABSTAIN
- ·No fractional shares issued; cash payment from aggregated sale proceeds
- ·New CUSIP post-split: 416906204
06-03-2026
Banc of California, Inc. filed a new universal shelf registration statement on Form S-3 (File No. 333-293930) on March 2, 2026, which became effective immediately and replaced the prior 2023 shelf registration (File No. 333-270328). On March 6, 2026, the Company filed a prospectus supplement for the resale of shares of its voting common stock by certain selling stockholders, as required by the Registration Rights Agreement dated November 30, 2023. A legal opinion from Silver, Freedman, Taff & Tiernan LLP was included as Exhibit 5.1.
- ·2023 Registration Statement filed March 7, 2023 (File No. 333-270328)
- ·Prior prospectus supplement filed March 1, 2024 under 2023 Registration Statement
- ·Registration Rights Agreement dated November 30, 2023
06-03-2026
Sonic Automotive, Inc. (SAH) filed Definitive Additional Proxy Materials (DEFA14A) on March 06, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing, marked as soliciting material under §240.14a-12, was submitted by the registrant with no fee required. No specific proposals, financial data, or substantive details are provided in the filing header.
06-03-2026
Velo3D, Inc. amended its January 2025 Senior Secured Convertible Note ($5M principal, now held by Arrayed Notes Acquisition Corp., controlled by CEO Arun Jeldi) to allow optional conversion of principal and accrued interest into common stock, following prior amendments extending maturity to February 14, 2027, and reducing interest to 12% per annum. The February 2025 Senior Secured Convertible Note ($10M principal, held by Thieneman Construction, Inc., controlled by director Kenneth Thieneman) was also amended to permit conversion of accrued interest into common stock, with the same prior maturity extension and interest rate reduction. No changes to principal amounts or other core terms were reported.
- ·January 2025 Note prior conversion price: $16.38 per share
- ·February 2025 Note prior conversion price: $10.50 per share
- ·Both notes maturity date extended to February 14, 2027 (prior amendment)
- ·Amendments dated March 4, 2026; filing dated March 6, 2026
06-03-2026
Athena Bitcoin's global Bitcoin ATM deployments declined 5% YoY from 3,111 in 2024 to 2,953 in 2025, while the overall ATM market grew modestly from 37.7 thousand to 39.2 thousand machines, with Australia showing the strongest regional growth at 43%. Global cryptocurrency owners rose 12.4% YoY to 741 million in 2025, driven by Ethereum owners (+22.6% to 175 million), though Bitcoin owners grew more slowly at 8.3% to 365 million.
- ·Athena Bitcoin, Inc. owns 99% of Athena Holdings El Salvador S.A. de C.V. (Eric Gravengaard holds 1% on behalf of company).
- ·Athena Bitcoin, Inc. beneficially owns Athena Holdings Colombia SAS (nominally Eric Gravengaard 95%, Matias Goldenhörn 5%).
- ·Australia added 600 Bitcoin ATMs (fastest growth).
- ·Potential 300,000 to 1.2 million additional people invested in BTC via US spot ETFs.
- ·Historical Athena Bitcoin ATMs: 65 (2017), 445 (2022), 1,829 (2023).
06-03-2026
Vine Hill Capital Investment Corp., a SPAC, is seeking shareholder approval for a business combination involving a merger with Odysseus (Cayman) Limited and acquisition of CoinShares International Limited via a $1.2B equity value Scheme of Arrangement, resulting in CoinShares becoming the primary subsidiary of renamed Holdco (CoinShares PLC). A $50M PIPE investment from an institutional investor provides 6,666,667 Holdco shares, supporting the deal. However, pro forma ownership for Vine Hill public shareholders ranges from 14.3% (no redemption) to 0% (maximum redemption), highlighting significant dilution risk from potential redemptions totaling up to $231.5M at ~$10.52 per share.
- ·Business Combination Agreement dated September 8, 2025.
- ·PIPE Investor holds 1,967,329 Vine Hill Class A Shares as of most recent Schedule 13G.
- ·CoinShares Options: 723,038 Holdco Ordinary Shares underlying assumed options (excluded from pro forma table).
- ·Redemption price estimate: $10.52 per share based on Trust Account as of September 30, 2025.
- ·Holdco to list Ordinary Shares on Nasdaq under 'CS' and Warrants under TBD symbol.
06-03-2026
On March 3, 2026, Valmont Industries, Inc. dismissed Deloitte & Touche LLP as its independent registered public accounting firm and appointed KPMG LLP for the fiscal year ending December 26, 2026, following Audit Committee approval. There were no disagreements, reportable events, or prior consultations with KPMG during fiscal years ended December 27, 2025, and December 28, 2024, and Deloitte's audit reports for those years were unqualified. Deloitte provided a concurring letter as Exhibit 16.1.
- ·Appointment of KPMG subject to completion of client acceptance procedures and execution of engagement letter.
- ·Deloitte's letter dated March 5, 2026, filed as Exhibit 16.1.
06-03-2026
On March 4, 2026, Funko, Inc. and its subsidiary Funko UK, Ltd. entered into a Letter Agreement amending Andrew Oddie's Service Agreement dated May 12, 2022 (as previously modified), changing his title to Chief International Officer, eliminating his U.S. residency requirement for employment, and removing certain relocation terms while keeping his compensation otherwise unchanged. The amendment does not indicate any departure or new appointment but adjusts existing terms. Full details are in Exhibit 10.1.
- ·Original Service Agreement dated May 12, 2022, modified by letters dated May 1, 2024 and September 9, 2024.
- ·Filing signed on March 6, 2026.
06-03-2026
Salesforce, Inc. announced that Robin Washington, its Chief Operating and Financial Officer, will assume the additional role of principal accounting officer effective March 9, 2026, as part of an internal finance reorganization. She will receive no compensation adjustment for this role. Sundeep Reddy will remain as Chief Accounting Officer.
- ·Announcement part of internal finance reorganization
- ·Washington's biographical information disclosed in Proxy Statement for 2025 Annual Meeting of Stockholders
- ·No arrangements or understandings with other persons for selection as PAO
- ·No family relationships with directors or executive officers
- ·No direct or indirect material interest in transactions per Item 404(a) of Regulation S-K
06-03-2026
Bridger Aerospace Group Holdings, Inc. reported FY2025 revenues of $122.8M, up 25% YoY from $98.6M, with strong growth in aerial surveillance (+33%), MRO (+54%), and fire suppression (+20%), though other services declined 16%. The company achieved net income of $4.1M, reversing a $15.6M loss, with Adjusted EBITDA up 21% to $45.3M from $37.3M; however, SG&A expenses were flat at up 1%, cash and equivalents fell to $31.4M from $39.3M due to investing outflows, and loss attributable to common stockholders improved to $22.9M but remained negative with EPS of -$0.42.
- ·Net cash provided by operating activities increased to $16.7M in FY2025 from $9.4M in FY2024.
- ·Net cash used in investing activities was $34.4M in FY2025 vs provided $2.1M in FY2024.
- ·Total liabilities rose to $265.6M as of Dec 31, 2025 from $237.3M.
- ·Stockholders’ deficit widened to $342.6M from $326.7M.
- ·Revenues from Spain grew 39% YoY to $14.0M, while US revenues up 23% to $108.8M.
06-03-2026
O’Reilly Automotive, Inc. entered into an Underwriting Agreement on March 5, 2026, with BofA Securities, Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC as representatives of the underwriters for the issuance and sale of $850M aggregate principal amount of 5.100% Senior Notes due 2036. Estimated net proceeds of approximately $841M will be used to repay outstanding 3.550% senior notes due 2026 at maturity, repay a portion of commercial paper borrowings, and for general corporate purposes including working capital, share repurchases, acquisitions, and related fees.
- ·Underwriting Agreement includes customary representations, warranties, covenants, and indemnification of underwriters against certain liabilities.
- ·Common stock ($0.01 par value) trades on NASDAQ Global Select Market under symbol ORLY.
06-03-2026
NVIDIA Corporation's Compensation Committee adopted the Variable Compensation Plan for Fiscal Year 2027 on March 2, 2026, providing eligible executive officers with variable cash payments based on FY2027 revenue performance goals at threshold, base, and stretch levels. CEO Jen-Hsun Huang has a base target award of $4M (200% of FY2027 base salary), while Colette M. Kress, Ajay K. Puri, Debora Shoquist, and Timothy S. Teter each have $1.5M targets (150% of base salary). Eligibility requires continued employment through the payment date.
- ·Fiscal Year 2027 ends January 31, 2027
- ·Performance goals based on FY2027 revenue with threshold, base, and stretch compensation plan levels
- ·Filed as Exhibit 10.1
06-03-2026
Sonic Automotive, Inc. (SAH) issued its DEF 14A Proxy Statement for the 2026 Annual Meeting on April 29, 2026, seeking stockholder approval for electing nine directors, ratifying Grant Thornton LLP as independent auditor for fiscal 2026, advisory approval of fiscal 2025 named executive officer compensation, the 2026 Equity Incentive Plan, and amendment/restatement of the 2012 Formula Restricted Stock and Deferral Plan for Non-Employee Directors. The Board unanimously recommends voting 'FOR' all proposals. Record date is March 2, 2026, with 21.5M Class A shares (1 vote each) and 12.0M Class B shares (10 votes each) outstanding.
- ·Annual Meeting at 2:00 p.m. ET on April 29, 2026, at 4401 Colwick Road, Charlotte, North Carolina 28211.
- ·Voting deadline for telephone/Internet: 11:59 p.m. ET on April 28, 2026.
- ·Majority of votes cast required for approval of all proposals; abstentions and broker non-votes do not count as votes cast.
- ·Proposal 2 (auditor ratification) is routine, allowing broker discretionary votes; others are non-routine.
06-03-2026
On March 3, 2026, the Board of Directors of GoodRx Holdings, Inc., upon recommendation of the Compensation Committee, approved a discretionary cash bonus of $72,918 for 2025 performance to Romin Nabiey, the company's Chief Accounting Officer. The 8-K filing was submitted on March 6, 2026, and signed by Christopher McGinnis, Chief Financial Officer & Treasurer. No other financial metrics, performance comparisons, or changes in officer status were disclosed.
- ·Event date: March 3, 2026
- ·Filing date: March 6, 2026
- ·Company address: 2701 Olympic Boulevard, Santa Monica, California 90404
06-03-2026
FirstSun Capital Bancorp's 2025 net income rose 29.5% YoY to $97.9M from $75.6M, supported by net interest income growth of 6.9% to $317.4M and noninterest income up 13.4% to $101.9M, while total assets expanded 4.8% to $8.5B and deposits grew 6.5% to $7.1B. However, noninterest expenses increased 2.9% to $271.8M, provision for credit losses of $24.6M remained elevated above 2023's $18.2M, net charge-offs rose to 0.43% from 0.32%, and key profitability ratios like ROE at 8.88% and NIM at 4.10% trailed 2023 levels of 12.50% and 4.23%, respectively.
- ·No cash dividends declared or paid in 2025, 2024, or 2023.
- ·Merger related expenses net of tax: $2.6M in 2025 (down from $9.9M in 2024).
- ·Total risk-based capital ratio: 15.73% in 2025 (up from 15.42% in 2024).
- ·Loan to deposit ratio declined to 93.9% in 2025 from 95.6% in 2024.
- ·Allowance for credit losses to loans: 1.27% in 2025 (down from 1.38% in 2024).
06-03-2026
On March 2, 2026, the Audit Committee of Joby Aviation, Inc. dismissed Deloitte & Touche LLP as its independent registered public accounting firm effective immediately and appointed PricewaterhouseCoopers LLP (PwC) as the new firm for the fiscal year ending December 31, 2026, subject to standard procedures. Deloitte's audit reports for fiscal years ended December 31, 2025 and 2024 were unqualified with no disagreements or reportable events noted through the interim period to March 2, 2026. Deloitte was informed on March 3, 2026, and provided a concurring letter as Exhibit 16.1.
- ·No consultations with PwC occurred in fiscal years 2024 and 2025 or interim period through March 2, 2026, regarding accounting principles, audit opinions, disagreements, or reportable events.
- ·Securities registered: Common Stock (JOBY) and Warrants (JOBY WS) on New York Stock Exchange.
06-03-2026
Rogers Communications Inc filed its 40-F annual report for FY2025 ended December 31, 2025, detailing operations across Wireless, Cable, and Media segments with year-over-year comparisons to FY2024 and FY2023. The filing discloses the MLSE Transaction on July 1, 2025, involving Maple Leaf Sports & Entertainment Ltd., including assets classified as held for sale, property, plant & equipment, intangibles, and depreciation details. Equity structure includes Class A Voting Shares and Class B Non-Voting Shares, with notes on credit facilities like the Canada Infrastructure Bank Credit Facility due 2052; no specific performance improvements or declines quantified.
- ·Filing date: March 06, 2026
- ·Reporting period: January 1, 2025 to December 31, 2025
- ·Comparative periods: FY2024 (2024-01-01 to 2024-12-31) and FY2023
- ·MLSE Transaction date: July 1, 2025
- ·Disposal groups classified as held for sale: December 2025
- ·Credit facilities include Canada Infrastructure Bank Credit Facility Due 2052, Revolving Credit Facility 1, Accounts Receivable Securitization Program
06-03-2026
On February 25, 2026, American Rebel Holdings, Inc. received a $250,000 release from a deposit account control agreement tied to a prior $5.47M secured promissory note with Streeterville Capital, LLC. Simultaneously, the company exchanged 490 shares of Series E Preferred Stock for 2,450,000 shares of common stock via five Exchange Agreements, resulting in significant equity dilution for existing shareholders. These transactions were exempt from registration under Section 4(a)(2) and Regulation D.
- ·Original note purchase agreement dated June 26, 2025.
- ·Series E Preferred Stock originally issued pursuant to August 22, 2025 Note Purchase Agreement.
- ·Five identical Exchange Agreements executed, varying only in conversion amounts and shares.
06-03-2026
Spring Valley Acquisition Corp. III filed its 10-K annual report covering the period from inception on March 12, 2025, through December 31, 2025, highlighting risks such as insufficient working capital potentially requiring sponsor loans for the initial business combination within a 24-month window post-IPO. The filing discloses limitations from debt servicing on cash flow for dividends, acquisitions, and strategy execution, along with potential change of control issues from share issuances exceeding 60% of equity proceeds. Founder shares face transfer restrictions until one year post-combination or achievement of a $12.00 per share price threshold.
- ·Financial statements cover period from inception (March 12, 2025) through December 31, 2025
- ·Initial business combination must be completed within 24 months after IPO closing
- ·Founder shares non-transferable until earliest of: 1 year post-combination, or $12.00/share for 20 trading days in 30-day period starting 150 days post-combination, or liquidation event
06-03-2026
Howard Hughes Holdings Inc.'s Board of Directors determined on March 5, 2026, to hold the 2026 annual meeting of stockholders on June 4, 2026, with a record date of April 6, 2026. Due to the meeting date changing by more than 30 days from the 2025 annual meeting anniversary, deadlines for Rule 14a-8 stockholder proposals and bylaw nominations are both March 17, 2026, while universal proxy rule notices under Rule 14a-19 are due by April 5, 2026. Additional details will be in the definitive proxy statement.
- ·Stockholder proposals under Bylaws must be delivered not earlier than the 120th day prior to the Annual Meeting and not later than the 90th day prior or 10th day after public announcement if less than 100 days prior.
06-03-2026
Spring Valley Acquisition Corp. III (SVAC) is pursuing a business combination with General Fusion Inc. via a SPAC merger announced January 21, 2026, involving SVAC's continuance to British Columbia, amalgamation with NewCo, and renaming to General Fusion Group Ltd., targeting a NASDAQ listing mid-2026. The fireside chat highlights General Fusion's magnetized target fusion technology progress, with Lawson Machine 26 operational and funded through 2028 milestones (1 keV heating, 10 keV, 100% Lawson Criterion), backed by $230M SPAC trust as excess capital plus committed private funding, aiming for a 150 MW first-of-a-kind plant by 2035. No financial declines or challenges are noted beyond standard SPAC redemption risks, which are mitigated by secured funding.
- ·F-4 registration statement filed recently (early March 2026)
- ·Lawson program milestones: 1 keV heating, 10 keV heating, 100% Lawson Criterion by 2028
- ·Commercial systems demonstrations planned for execution starting 2027
- ·SPAC trust capital ($230M) considered 'gravy' beyond committed private funding sufficient for multi-year operations even with 100% redemptions
06-03-2026
IPG Photonics Corporation filed Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025, solely to correct the cover page disclosure regarding incorporation by reference to its proxy statement for the 2026 Annual Meeting; no changes were made to financial statements or other disclosures from the original filing on February 23, 2026. The amendment includes new Section 302 certifications but omits others as no financials are revised. Aggregate market value of non-affiliate common stock was approximately $1.8B as of June 30, 2025, with 42,191,353 shares outstanding as of February 20, 2026.
- ·Registrant is a large accelerated filer.
- ·Proxy statement for 2026 Annual Meeting to be filed within 120 days of December 31, 2025.
06-03-2026
On March 6, 2026, Iveda Solutions, Inc. received a Nasdaq notice stating its common stock (IVDA) failed to maintain a $1 minimum bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has 180 calendar days until September 2, 2026, to regain compliance by achieving a $1 closing bid for 10 consecutive business days, with no immediate listing impact but potential delisting risk thereafter. Warrants (IVDAW) are also referenced as listed on Nasdaq.
- ·Nasdaq Listing Rule 5810(c)(3)(A) governs the 180-day compliance period.
- ·Company headquartered at 1744 S. Val Vista, Suite 213, Mesa, Arizona 85204.
- ·Appeal to Nasdaq Hearings Panel possible if delisting notice issued.
06-03-2026
TOMI Environmental Solutions, Inc. filed an 8-K on March 6, 2026, providing a legal opinion related to its previously disclosed Equity Purchase Agreement with Hudson Global Ventures, LLC, dated November 5, 2025, which allows the Company to sell up to $20M of common stock over a 24-month period. The opinion, dated February 24, 2026, from Morgan, Lewis & Bockius LLP, is incorporated by reference into the Company's Form S-3 (File No. 333-291563). No new financial metrics or performance data were reported.
- ·Agreement initially disclosed on November 12, 2025
- ·Shares offered pursuant to Form S-3 (File No. 333-291563)
- ·24-month term for stock sales under the agreement
06-03-2026
Interactive Strength Inc. (TRNR) increased the maximum aggregate offering price of its common stock under the At-The-Market Offering Agreement with H.C. Wainwright & Co. LLC, dated May 17, 2024, to $6.057M on March 6, 2026, and filed a corresponding prospectus supplement. Prior to this amendment, the company had sold approximately $1.673M in shares over the last 12 calendar months pursuant to General Instruction I.B.6 of Form S-3 and $12.13M in aggregate under the Sales Agreement. No new shares were issued in this update.
- ·Shelf registration statement on Form S-3 (File No. 333-288405) filed June 27, 2025, declared effective September 22, 2025.
- ·Prospectus supplement originally filed January 23, 2026, amended March 6, 2026.
- ·Legal opinion on legality of shares from Lucosky Brookman LLP filed as Exhibit 5.1.
06-03-2026
Vicarious Surgical Inc. amended employment agreements for President Adam Sachs and CTO Sammy Khalifa, voluntarily reducing their annual base salaries to $270,810 and $318,600 respectively (50% and 25% cuts from prior levels), effective March 9, 2026, while preserving bonus and severance calculations on pre-amendment salaries. This cost-cutting measure occurs amid NYSE delisting proceedings initiated March 3, 2026, with shares now trading OTC under 'RBOT'. No departures or new appointments were announced.
- ·Amendments signed March 4, 2026, explicitly waive 'Good Reason' claims for salary reductions.
- ·Class A common stock delisted by NYSE on March 3, 2026, now quoted on OTCID tier as 'RBOT'.
06-03-2026
Medalist Diversified REIT, Inc.'s subsidiary, MDR Ashley Plaza, LLC, entered into a Purchase and Sale Agreement on March 5, 2026, to sell the 156,012 square foot Ashley Plaza retail property in Goldsboro, North Carolina, for total consideration of $16.6M, subject to prorations and adjustments. The purchaser, HPX Goldsboro Ashley Center LLC, must provide earnest money deposits totaling $300k. The transaction is expected to close within 90 days, though several conditions remain unsatisfied and there is no assurance of completion.
- ·Property address: 201–221 North Berkeley Boulevard, Goldsboro, North Carolina
- ·Closing expected within 90 days of March 5, 2026, subject to customary conditions, representations, warranties, covenants, and indemnities
06-03-2026
Diversified Energy Company (DEC) filed an 8-K on March 6, 2026, providing unaudited pro forma condensed combined financial information for the year ended December 31, 2025, related to its acquisition of Canvas Energy Inc., which closed on November 26, 2025. The pro forma statements are included as Exhibit 99.1. No specific financial metrics, period-over-period comparisons, or performance highlights (positive or negative) are detailed in the filing body.
- ·Acquisition of Canvas Energy Inc. previously announced and closed on November 26, 2025, as disclosed in prior 8-K.
- ·Pro forma financials cover statement of comprehensive income for year ended December 31, 2025.
06-03-2026
Five Point Holdings, LLC reported total revenues of $110.0M for the year ended December 31, 2025, down 54% YoY from $237.9M, driven by a 70% plunge in land sales to $42.5M from $139.1M and a 32% drop in management services-related party revenue to $65.3M, while operating properties revenue remained nearly flat at $2.3M. However, equity in earnings from unconsolidated entities surged 54% to $203.6M, boosting net income to $183.5M (up 3% YoY) and net income attributable to the company to $71.0M (up 4%), with Class A basic EPS rising to $1.01 from $0.98. Total assets grew to $3.25B, inventories increased to $2.44B, and notes payable declined to $443.3M from $525.7M.
- ·Cash flow from operating activities declined to $105.2M from $116.0M YoY.
- ·Valencia segment reported a loss of $(2.2)M in 2025 vs profit of $35.7M in 2024.
- ·San Francisco segment loss widened slightly to $(4.7)M from $(4.1)M YoY.
- ·Cash and cash equivalents decreased to $425.5M from $430.9M.
06-03-2026
Home Bancorp, Inc. reported net income of $46.1M for the year ended December 31, 2025, up 26% YoY from $36.4M, with diluted EPS increasing to $5.87 from $4.55 and ROA improving to 1.33% from 1.08%. Total assets grew 1.4% to $3.49B, deposits rose 6.9% to $2.97B, and net interest income increased 10.8% to $133.3M. However, asset quality deteriorated sharply with non-performing loans jumping to 1.25% of total loans from 0.50% and non-performing assets rising to 1.03% of total assets from 0.45%, while loans grew only 0.9% YoY.
- ·Provision for loan losses was $1.1M in 2025, down from $2.4M in 2024.
- ·Shareholders’ equity increased to $435.1M as of Dec 31, 2025 from $396.1M.
- ·Tier 1 risk-based capital ratio strengthened to 14.09% from 13.28%.
- ·Cash dividends per share rose to $1.14 in 2025 from $1.01.
06-03-2026
Grab Holdings Ltd reported FY2025 revenue of $3,370 million, up 20% YoY from $2,797 million, with Deliveries up 20% to $1,800 million, Mobility up 16% to $1,219 million, and Financial Services surging 37% to $347 million. The company achieved an operating profit of $65 million, swinging from a $168 million loss, and net profit of $200 million versus a $158 million loss. However, cost of revenue increased 18% to $1,914 million (57% of revenue vs. 58% prior), net impairment losses rose 47% to $140 million, and R&D expenses grew 4% to $428 million while G&A declined 10%.
- ·Revenue by country: Philippines +19% to $316M, Singapore +26% to $727M, Thailand +14% to $288M, Vietnam +12% to $255M.
- ·Sales and marketing expenses up 13% to $367M (11% of revenue vs 12% prior).
- ·Other income up 17% to $20M.
06-03-2026
BKV Corp reported total production of 305.0 Bcfe in 2025, up 5.7% YoY from 288.4 Bcfe in 2024, driven by Barnett growth (+10.2%) but offset by a sharp NEPA decline (-20.1%). Revenues surged 73.6% YoY to $1.01B, fueled by 75% higher natural gas revenues ($675.1M), though midstream revenues fell 17% and Section 45Q tax credits dropped 16%. PV-10 value jumped to $2.79B from $672M, while operating expenses rose 7.6% to $791.2M amid higher costs in several areas.
- ·Average production costs total company $1.32/Mcfe in 2025 vs $1.25/Mcfe in 2024 (+5.6%).
- ·DD&A expenses declined 28% YoY to $157.5M in 2025.
- ·Proved reserves PV-10 at Dec 31, 2025 alternative $3.08B.
06-03-2026
Greenidge reported preliminary Q4 2025 total revenue of $11.5M, down $3.7M or ~24% QoQ from Q3, with cryptocurrency mining revenue declining $1.6M and datacenter hosting down $3.0M, though power and capacity revenue improved $0.8M; net income fell to $1.9-2.9M QoQ. For FY2025, revenue was $58.8M, down $0.8M or ~1% YoY from FY2024, with mining revenue down $3.8M and bitcoin production down 570 to 371, but net income improved to $4.2-5.2M, power revenue rose $11.4M, and debt was reduced to $39M. The company secured 100MW of future power capacity and a Title V Air Permit renewal for the Dresden facility, supporting AI/HPC transition.
- ·Secured 60MW non-curtailable power at Dresden facility and 40MW at Mississippi greenfield site by Q1 2027.
- ·Initiated NYISO study for additional 200MW at Dresden.
- ·Agreement with NYSDEC for Dresden permit renewal post-public comment, extending C-Pond closure to Oct 2027.
- ·Senior unsecured debt reduced from $157.5M in 2023 and $68.5M at FY2024 end to $39M.
- ·SG&A expenses reduced from $26.1M in 2023 to $12.1M in FY2025.
06-03-2026
Aptiv PLC announced that its subsidiary Versigent Limited filed an amended Form 10 registration statement with the SEC for the planned separation of its Electrical Distribution Systems business into a new independent publicly traded company via a tax-free spin-off to shareholders. The transaction is expected to complete by April 1, 2026, subject to customary closing conditions. No financial metrics or performance data were disclosed in the filing.
- ·Amended Registration Statement on Form 10 publicly filed on March 6, 2026
- ·Copy of amended Form 10 available on SEC website at www.sec.gov
06-03-2026
Boeing's 2026 DEF 14A Proxy Statement discloses 2025 compensation for named executive officers (NEOs), with CEO Robert K. Ortberg receiving total pay of $23.6M, up 28% from $18.4M in 2024, driven by $9.6M in option awards and $3.9M incentive pay. Other NEOs like Stephanie F. Pope saw total comp rise 44% to $14.4M from $10.0M, while new CFO Jesus Malave, Jr. earned $20.2M including an $8.5M bonus; however, stock option grants to NEOs in February 2025 occurred amid a 3.8% decline in share price following material nonpublic information disclosure. The filing reaffirms robust clawback and insider trading policies with no interlocks or excessive risk in comp design.
- ·No stock options granted to NEOs during blackout periods around 10-K/10-Q/8-K filings except specified Feb 2025 grants.
- ·Clawback policy adopted June 27, 2023, applies to incentive comp earned on/after Oct 2, 2023.
- ·No Compensation Committee interlocks in 2025; independent review by FW Cook confirms no excessive risk in comp programs.
06-03-2026
Global Mofy AI Ltd filed an F-3 shelf registration statement on March 6, 2026, enabling potential future offerings of securities without specific amounts or uses detailed at this time. The company reports authorized share capital of $1.02M, divided into 30B Class A ordinary shares and 4B Class B ordinary shares, each with a par value of $0.00003. As of the prospectus date, 45.8M Class A shares and 5.7M Class B shares are outstanding, with Class B shares carrying 20 votes per share compared to 1 vote for Class A.
- ·Incorporated as a Cayman Islands exempted company on September 29, 2021.
- ·Former name: Global Mofy Metaverse Ltd (changed February 25, 2022).
- ·Class A Ordinary Shares: 1 vote per share; Class B Ordinary Shares: 20 votes per share.
- ·SEC file number: 333-294113.
06-03-2026
The Invesco Galaxy Solana ETF (QSOL) reported net assets of $2.24M as of December 31, 2025, with 180,000 shares outstanding, NAV per share of $12.45, and investments in Solana valued at $2.24M (cost basis $2.49M). For the inaugural period from October 16 to December 31, 2025, it generated $1,445 in staking income (net investment income $1,186) but suffered a $244,798 unrealized loss on Solana holdings and sponsor fees of $259, resulting in a net loss of $243,612. Total return at NAV was -50.20% over the full period (or -10.04% annualized from December 10 commencement of operations), while market value per share ended at $12.41.
- ·Commencement of operations: December 10, 2025
- ·Commencement of trading on exchange: December 15, 2025
- ·Net asset value per share at beginning of Dec 10-31 period: $13.84
- ·Paid-in capital: $2,485,077
- ·Distributable earnings (loss): $(243,612)
- ·Cash held by custodian: $500
06-03-2026
Boeing issued Definitive Additional Proxy Materials (DEFA14A) providing voting instructions and access details for its 2026 Annual Meeting of Shareholders, to be held virtually on April 17, 2026, at 9:00 a.m. ET via www.virtualshareholdermeeting.com/BA2026. Voting deadlines are April 9, 2026 (11:59 p.m. ET) for 401(k) plan participants and April 16, 2026 (11:59 p.m. ET) for registered shareholders, with options via www.proxyvote.com or 1-800-690-6903. The 2026 Proxy Statement and 2025 Annual Report are available at https://materials.proxyvote.com/097023.
- ·Virtual meeting webcast opens at 8:45 a.m. ET on April 17, 2026
- ·Attendance limited to registered and beneficial shareholders as of record date, on first-come, first-served basis due to capacity limits
- ·Paper copies of materials requestable via 1-800-579-1639 or sendmaterial@proxyvote.com
06-03-2026
Drugs Made In America Acquisition II Corp. disclosed that its sponsor made improper withdrawals (Irregularities) from the working capital account between the IPO on September 26, 2025, and December 31, 2025. The board confirmed these did not affect the Trust Account, which holds approximately $507.8M as of March 6, 2026. No other financial impacts or period-over-period metrics were reported.
- ·Irregularities occurred between September 26, 2025 (IPO completion) and December 31, 2025
- ·Securities: Units (DMIIU), Ordinary Shares (DMII), Rights (DMIIR) listed on Nasdaq
06-03-2026
NeOnc Technologies Holdings, Inc. (NTHI) announced on March 4, 2026, data from the dose-escalation portion of its Phase 1/2 clinical trial for NEO212 via a press release (Exhibit 99.1). The company hosted an investor conference call to discuss the data, furnishing the investor presentation (Exhibit 99.2) and call transcript (Exhibit 99.3). The disclosures are under Regulation FD and not deemed 'filed' for liability purposes.
06-03-2026
Drugs Made In America Acquisition Corp. confirmed that irregularities, consisting of improper withdrawals by the sponsor from its affiliate Drugs Made In America Acquisition II Corp.'s working capital account between September 26, 2025, and December 31, 2025, did not impact the Company's Trust Account. As of March 6, 2026, the Trust Account balance stands at approximately $241.3M, providing reassurance to investors. No losses or declines were reported for the Company's funds.
- ·Irregularities occurred between completion of affiliate's IPO on September 26, 2025, and December 31, 2025.
- ·Company's securities trade on Nasdaq Stock Market LLC.
06-03-2026
Planet 13 Holdings Inc. terminated the employment of its Chief Administrative Officer, Lee Fraser, effective March 6, 2026, following his placement on administrative leave on January 5, 2026. The 8-K filing was signed by Co-Chief Executive Officers Robert Groesbeck and Larry Scheffler. No additional financial or operational impacts were disclosed.
- ·Company is an emerging growth company.
- ·Principal executive offices: 2548 West Desert Inn Road, Suite 100, Las Vegas, Nevada 89109.
- ·I.R.S. Employer Identification Number: 83-2787199.
06-03-2026
The Boeing Company has filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Shareholders on April 17, 2026, at 9:00 A.M. ET (virtual). The Board recommends voting FOR the election of 12 director nominees, advisory approval of Named Executive Officer compensation, and ratification of Deloitte & Touche LLP as independent auditor for 2026, but AGAINST two shareholder proposals on establishing a Board Committee on Disability Access and allowing action by written consent.
- ·Vote deadline: April 16, 2026, 11:59 PM ET
- ·Request proxy materials by: April 3, 2026
- ·Virtual meeting URL: www.virtualshareholdermeeting.com/BA2026
- ·2025 Annual Report available with proxy materials
06-03-2026
AMC Entertainment Holdings, Inc. entered a commitment letter with Deutsche Bank AG New York Branch for a new $425M senior secured credit facility for subsidiary Odeon Finco PLC to refinance its 12.750% Senior Secured Notes due 2027, featuring a 10.50% fixed interest rate term loan due 2031 with 2.00% OID, expected to strengthen the balance sheet, extend maturities, and reduce interest costs upon closing by April 6, 2026. The company decided not to proceed with its previously announced senior notes and term loan offering. AMC operates approximately 855 theatres and 9,640 screens globally.
- ·Odeon Credit Facility subject to definitive documentation and customary closing conditions
- ·Company operates as largest movie exhibition company in US, Europe, and worldwide
06-03-2026
Mammoth Energy Services reported total revenue of $44.3M for 2025, down 2.9% YoY from $45.6M, with growth in rental services (+56%) and infrastructure services (+177%) offset by declines in natural sand proppant (-13%), accommodation (-17%), and other services (-100%). While net loss from continuing operations narrowed to $63.8M from $183.1M, driven by lower SG&A and Adjusted EBITDA loss improving to $17.4M from $171.2M, a $31.7M impairment charge impacted results; overall net income turned positive at $4.6M due to $68.4M gain from discontinued operations. Cash and equivalents rose to $102.0M from $60.8M, but total assets declined to $334.9M from $384.0M.
- ·Capital expenditures totaled $70.6M in 2025, up significantly from $1.2M in 2024, primarily in rental services ($70.0M).
- ·Net cash used in operating activities from continuing operations was $19.6M in 2025 vs provided $194.7M in 2024.
- ·SG&A expenses decreased to $19.6M from $114.5M YoY.
- ·Revolving credit facility borrowing base increased to $50.0M from $25.2M as of Dec 31.
06-03-2026
Fairfax Financial Holdings Limited (FRFXF) filed its Form 40-F annual report for the fiscal year ended December 31, 2025, on March 6, 2026, incorporating IFRS disclosures on insurance contracts, investments, associates, and segments including Property & Casualty Insurance & Reinsurance, Life Insurance & Run-off, Non-Insurance, and Investment Management. The report details maturity analyses of liabilities in USD, GBP, EUR, and CAD across time buckets (not later than one year, 1-5 years, 5-10 years, 10-15 years), fair value inputs for investment properties, intangibles, and sensitivities, with references to global subsidiaries and associates but no specific numerical financial results in the provided content. Prior year (2024) comparisons are indicated structurally across segments and geographies including North America, Europe, International, Asia, India, and Latin America.
- ·Geographic disclosures include US, CA, Europe.
- ·Segments: NorthAmericanInsurers, InternationalInsurersAndReinsurers, GlobalInsurersAndReinsurers, RunoffReportableSegment, RestaurantsAndRetail, FairfaxIndia.
06-03-2026
Hennessy Capital Investment Corp. VII (HVII), a SPAC, filed its 10-K on March 6, 2026, disclosing a Proposed Business Combination with ONE Nuclear Energy LLC per agreement dated October 22, 2025, with a 24-month completion window from IPO closing. The filing details a $6.9M private placement of 690,000 units at $10.00 each, permitted withdrawals up to 5.0% of trust interest annually, and highlights experienced board members; however, it emphasizes extensive SPAC-specific risks including failure to complete a business combination, liquidity issues, conflicts of interest, and regulatory challenges.
- ·24 months from IPO closing as completion window for initial business combination, after which public shares redeem at ~$10.00 per share
- ·Private placement units consist of one Class A ordinary share and one right to 1/12 Class A ordinary share upon business combination
- ·Form S-4 (File No. 333-292440) filed for Proposed Business Combination
06-03-2026
For Q3 FY2025, Greenwave Technology Solutions reported revenue growth of 49% YoY to $12.7M, driven by higher sales, while gross profit was nearly flat at $3.5M and net loss widened to $5.3M amid higher operating expenses. Over the nine months ended September 30, 2025, revenue rose 25% YoY to $31.0M with flat gross profit of $9.1M, operating loss improved to $13.5M from $16.2M, but net loss available to common stockholders was $17.9M; total assets declined 5% to $59.9M, cash fell to $1.5M, and stockholders' equity dropped 12% to $32.7M with substantial doubt about going concern.
- ·Related party property and equipment net declined to $10.7M from $11.8M.
- ·Non-convertible notes payable increased to $7.96M total (current + long-term) from $6.77M.
- ·Operating cash flow used $5.9M in 9M 2025 vs $14.8M in 9M 2024 (improved).
- ·Financing activities provided $5.8M net cash in 9M 2025, primarily from common stock and warrants issuance.
- ·Substantial doubt about going concern noted.
- ·Nasdaq listing standards risk and ineligibility for Form S-3 mentioned.
06-03-2026
Grayscale Avalanche Trust (AVAX) filed Amendment No. 6 to its Form S-1 registration statement (No. 333-289829) on March 6, 2026, to register an indeterminate number of Shares for continuous public offering and listing on NASDAQ under the symbol GAVA, with plans to rename to Grayscale Avalanche Trust ETF upon effectiveness. The Trust holds AVAX digital assets to provide investors exposure via Shares created/redeemed in Baskets of 10,000 Shares, primarily in-kind with AVAX or via cash orders through Authorized Participants. No prior public market exists for the Shares, and the filing notes the Trust's status as a non-accelerated filer, smaller reporting company, and emerging growth company.
- ·Registration No. 333-289829
- ·Trust incorporated in Delaware with SIC code 6221 and I.R.S. Employer ID 99-6715858
- ·Index Price based on CoinDesk Avalanche Benchmark Rate at 4:00 p.m. New York time
- ·NASDAQ approval for in-kind creations/redemptions with AVAX
06-03-2026
Ategrity Specialty Insurance Co Holdings (ASIC) reported robust growth for the year ended December 31, 2025, with gross written premiums up 33.1% YoY to $582M, net written premiums surging 41.9% to $425M, and underwriting income increasing 141.2% to $43M, leading to net income of $76M (up 41.1% YoY) and an improved combined ratio of 88.2% from 93.9%. Net investment income rose 76.2% to $42M, boosting income before taxes by 44.7% to $96M. However, net realized and unrealized gains on investments declined 55.0% to $13M, cash equivalents investment income fell 58.0%, and net cash used in investing activities widened to $274M from $363M.
- ·Loss ratio improved to 58.7% from 60.3% YoY.
- ·Expense ratio declined to 29.5% from 33.6% YoY.
- ·Diluted EPS increased to $1.58 from $1.28 YoY.
- ·Adjusted diluted EPS rose to $1.61 from $1.32 YoY.
- ·Net cash change was positive $3M in 2025 vs negative $238M in 2024.
06-03-2026
Bunker Hill Mining Corp. reported total assets of $151M as of Dec 31, 2025, up 55% YoY from $98M, driven by process plant investments ($97M) and increased cash to $19M from $4M, supported by $73M in net financing inflows primarily from equity issuances that quadrupled shares outstanding to 40M. However, the company posted a net loss of $93M, more than tripling the prior year's $25M loss due to $49M silver loan fair value loss and $43M derivative liability change, while total liabilities rose 38% to $207M and shareholders' deficiency worsened to $56M from $52M. Operating cash use intensified to $18M from $10M amid ongoing pre-production development.
- ·Process plant increased to $97.2M from $66.4M (+46%) due to $36.4M expenditures.
- ·Silver loan liability surged to $80.7M from $31.8M amid $49.4M fair value loss.
- ·Derivative warrant liability jumped to $75.2M from $1.1M.
- ·Forward-looking Bunker Hill Project NPV (5%) $63M, IRR 36%, payback 2.1 years; annual avg Zinc eq production 93M lbs.
- ·Ongoing Crescent Mine litigation risk noted.
06-03-2026
Reservoir Media, Inc. entered into amended and restated employment agreements effective April 1, 2026, with CEO Golnar Khosrowshahi, President & COO Rell Lafargue, and CFO James Heindlmeyer, superseding prior agreements to retain these Named Executive Officers. Base salaries are set at $600,000 for Khosrowshahi and Lafargue (with 3% annual increases) and $425,000 for Heindlmeyer (with 3% annual increases), alongside target cash bonuses of 100% of base salary for the former two and 50% for the latter, plus immediate-vesting equity awards of 100% and 75% of base salary respectively. Initial terms are three years for each, with automatic or optional renewals and board re-appointment rights, plus customary non-compete and termination provisions.
- ·Agreements signed March 5, 2026; Khosrowshahi term auto-renews every 2 years after initial 3 years; Lafargue and Heindlmeyer terms have Company option to extend by 2 years
- ·Exhibits 10.1, 10.2, 10.3 contain full agreements
Get daily alerts with 12 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 110 filings
🇺🇸 More from United States
View all →March 26, 2026
US Pre-Market SEC Filings Roundup — March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals — March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) — March 25, 2026
New Drug Approvals (Original)